Reporting period: 2026-03-31 · Number of holdings: 1
Decas Capital LLC disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Recent moves
Unchanged 000000000
$0.0
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
✓
Ikena Oncology INC
Stock-Other
—
—
—
Portfolio Performance
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 0 months of available history
Stdev
—
Beta
—
Alpha
—
Max Drawdown
—
Annualized Perf
—
Batting Avg vs S&P
—
Sortino
—
Stutzer
—
Treynor
—
Sterling
—
Calmar
—
Information Ratio
—
Tracking Error
—
Stdev Down
—
Winning Months %
—
Losing Months %
—
Best 12 Months
—
Worst 12 Months
—
Efficiency Ratio
—
Sharpe
—
Stdev Sectors
—
Skewness
—
Kurtosis
—
Upside Potential
—
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
Period
Holdings
Total value
Stability
Top holdings
2026-03-31
1
—
0
2025-12-31
1
—
0
2025-09-30
1
—
0
2025-06-30
1
—
0
2025-03-31
1
—
0
2022-09-30
1
—
0
2022-06-30
1
—
0
2022-03-31
1
—
0
Holding changes this quarter
Position changes disclosed by Decas Capital LLC for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
What is Decas Capital LLC and what type of investor is it?
Decas Capital LLC is an investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Decas Capital LLC's largest equity positions?
Based on the latest 13F filing, Decas Capital LLC's top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Decas Capital LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Decas Capital LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Decas Capital LLC focus on?
Sector breakdown data is not yet available for Decas Capital LLC. Check back after the next 13F processing cycle.